Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pricing
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
congress
drug prices
house of representatives
medicare
negotiation
pbms
pharmacy benefit managers
sanofi
senate
2019
abbvie
What
drug
3
×
lower
prices
advanced
alnylam’s
anathema
approval
awaited
away
bff
bio
bringing
ceos
conference
dc
deals
democrat
details
devoted
disease
easl
elements
executives
form
gathered
gene
groups
hearing
held
house
kicked
leaked
liver
long
look
major
monday
night
pharma
pharmaceutical
Language
unset
Current search:
pricing
×
" san francisco top stories "
×
" san diego top stories "
×
drug
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away